US Patent 9789183 Anti-PD-L1 antibodies
Patent 9789183 was granted and assigned to Agency for Science, Technology and Research on October, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+163 characters)
Article
Patent abstract
Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Cheng-I Wang0
Hsueh Ling Janice Oh0
Siok Ping Yeo0
Edits on 28 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09789183 Anti-PD-L1 antibodies US Patent 9789183 Anti-PD-L1 antibodies
Infobox
Patent Number
09789183
Patent Number
9789183
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09789183 Anti-PD-L1 antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09789183
Date of patent
October 17, 2017
Patent application number
15623679
Date Filed
June 15, 2017
Patent primary examiner
Find more entities like US Patent 9789183 Anti-PD-L1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
